Millennium Pharmacon International Past Earnings Performance
Past criteria checks 4/6
Millennium Pharmacon International has been growing earnings at an average annual rate of 24%, while the Healthcare industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 6% per year. Millennium Pharmacon International's return on equity is 11.9%, and it has net margins of 1%.
Key information
24.0%
Earnings growth rate
25.4%
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 6.0% |
| Return on equity | 11.9% |
| Net Margin | 1.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Millennium Pharmacon International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3,363,518 | 33,088 | 193,007 | 0 |
| 30 Sep 23 | 3,247,238 | 27,353 | 193,234 | 0 |
| 30 Jun 23 | 3,219,223 | 33,687 | 189,923 | 0 |
| 31 Mar 23 | 3,140,964 | 19,205 | 191,108 | 0 |
| 31 Dec 22 | 3,200,833 | 24,464 | 186,311 | 0 |
| 30 Sep 22 | 3,110,806 | 23,400 | 181,647 | 0 |
| 30 Jun 22 | 3,108,303 | 20,180 | 180,406 | 0 |
| 31 Mar 22 | 3,118,516 | 19,784 | 176,728 | 0 |
| 31 Dec 21 | 2,988,849 | 9,571 | 176,214 | 0 |
| 30 Sep 21 | 2,964,455 | 9,106 | 170,558 | 0 |
| 30 Jun 21 | 2,722,038 | 2,264 | 164,061 | 0 |
| 31 Mar 21 | 2,542,135 | -3,080 | 158,426 | 0 |
| 31 Dec 20 | 2,643,627 | 2,804 | 159,860 | 0 |
| 30 Sep 20 | 2,650,598 | 2,481 | 163,080 | 0 |
| 30 Jun 20 | 2,732,457 | 3,937 | 161,244 | 0 |
| 31 Mar 20 | 2,834,147 | 10,608 | 164,238 | 0 |
| 31 Dec 19 | 2,726,755 | 7,880 | 159,781 | 0 |
| 30 Sep 19 | 2,663,271 | 11,359 | 155,048 | 0 |
| 30 Jun 19 | 2,606,487 | 15,927 | 152,239 | 0 |
| 31 Mar 19 | 2,501,354 | 20,139 | 144,816 | 0 |
| 31 Dec 18 | 2,376,183 | 19,444 | 140,904 | 0 |
| 30 Sep 18 | 2,289,136 | 19,468 | 135,889 | 0 |
| 30 Jun 18 | 2,217,576 | 18,354 | 134,762 | 0 |
| 31 Mar 18 | 2,161,385 | 13,437 | 130,654 | 0 |
| 31 Dec 17 | 2,110,825 | 14,180 | 125,820 | 0 |
| 30 Sep 17 | 2,064,637 | 13,749 | 122,448 | 0 |
| 30 Jun 17 | 1,981,731 | 9,082 | 119,826 | 0 |
| 31 Mar 17 | 1,992,987 | 12,039 | 119,624 | 0 |
| 31 Dec 16 | 1,970,114 | 11,106 | 118,248 | 0 |
| 30 Sep 16 | 1,921,310 | 11,723 | 109,001 | 0 |
| 30 Jun 16 | 1,871,476 | 14,723 | 106,264 | 0 |
| 31 Mar 16 | 1,784,412 | 12,970 | 103,575 | 0 |
| 31 Dec 15 | 1,707,613 | 11,907 | 101,258 | 0 |
| 30 Sep 15 | 1,639,664 | 13,349 | 98,022 | 0 |
| 30 Jun 15 | 1,575,673 | 11,018 | 95,176 | 0 |
| 31 Mar 15 | 1,497,480 | 7,044 | 92,743 | 0 |
| 31 Dec 14 | 1,437,668 | 7,340 | 89,155 | 0 |
| 30 Sep 14 | 1,392,032 | 5,865 | 96,644 | 0 |
| 30 Jun 14 | 1,369,266 | 8,103 | 94,625 | 0 |
| 31 Mar 14 | 1,342,030 | 9,980 | 91,959 | 0 |
| 31 Dec 13 | 1,310,244 | 10,247 | 89,708 | 0 |
| 30 Sep 13 | 1,273,244 | 10,788 | 88,104 | 0 |
| 30 Jun 13 | 1,230,816 | 9,711 | 85,338 | 0 |
Quality Earnings: SDPC has a large one-off gain of IDR12.7B impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: SDPC's current net profit margins (1%) are higher than last year (0.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SDPC's earnings have grown significantly by 24% per year over the past 5 years.
Accelerating Growth: SDPC's earnings growth over the past year (35.2%) exceeds its 5-year average (24% per year).
Earnings vs Industry: SDPC earnings growth over the past year (35.2%) exceeded the Healthcare industry 0.5%.
Return on Equity
High ROE: SDPC's Return on Equity (11.9%) is considered low.